Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to -$12.5 million.

  • Arrowhead Pharmaceuticals' Non Operating Income rose 850.18% to -$12.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$45.6 million, marking a year-over-year decrease of 8190.8%. This contributed to the annual value of -$46.8 million for FY2025, which is 31136.2% down from last year.
  • According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' Non Operating Income is -$12.5 million, which was up 850.18% from -$8.0 million recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' 5-year Non Operating Income high stood at $2.8 million for Q1 2022, and its period low was -$13.7 million during Q4 2024.
  • For the 5-year period, Arrowhead Pharmaceuticals' Non Operating Income averaged around -$3.1 million, with its median value being -$584500.0 (2023).
  • In the last 5 years, Arrowhead Pharmaceuticals' Non Operating Income soared by 41823.53% in 2024 and then tumbled by 133925.47% in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Non Operating Income (Quarter) stood at -$707000.0 in 2021, then surged by 171.71% to $507000.0 in 2022, then crashed by 522.88% to -$2.1 million in 2023, then plummeted by 539.13% to -$13.7 million in 2024, then increased by 8.5% to -$12.5 million in 2025.
  • Its Non Operating Income stands at -$12.5 million for Q4 2025, versus -$8.0 million for Q3 2025 and -$13.5 million for Q2 2025.